Anhui Healstar Pharmaceutical Co., Ltd. engages in production and sales of self-produced tablets, capsules, granules, small-volume injections, and raw materials. Its products include dipotassium phosphate, potassium dihydrogen phosphate, doxofylline, levofloxacin hydrochloride injection, doxofylline injection, compound potassium hydrogen phosphate injection, lysine calcium hydrogen phosphate granules, oral rehydration salt powder, dequinium chloride lozenges and potassium citrate granules. The company was founded on November 25, 2005 and is headquartered in Hefei, China.